Senior insider sale
Senior Vice President, CCO at Y-MABS THERAPEUTICS, INC. — senior position signals high conviction
$27.8K
1.68K shares
What this filing means
SMITH SUSAN LAURA plans to sell 1.68K shares of Y-MABS THERAPEUTICS, INC. valued at approximately $27.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/6/2024ACC: 0001964306-24-000145
Officer· Senior Vice President, CCO
Since Dec 2021
1.68K
Shares to sell
$27.8K
Approx. market value
1.68K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
1/17/2024
1.68KTotal acquired1.68K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/17/2024 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 1.68K | — |
| Total | 1.68K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.68K
Market value
$27.8K
3/5/2024
Total
Units
1.68K
Value
$27.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/5/2024 | 1.68K | $27.8K | NASDAQ | Planned |
| Total | 1.68K | $27.8K | ||